Meshkat Dinarvand

1.1k total citations
18 papers, 876 citations indexed

About

Meshkat Dinarvand is a scholar working on Molecular Biology, Biomaterials and Cancer Research. According to data from OpenAlex, Meshkat Dinarvand has authored 18 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Biomaterials and 3 papers in Cancer Research. Recurrent topics in Meshkat Dinarvand's work include RNA Interference and Gene Delivery (12 papers), Advanced biosensing and bioanalysis techniques (8 papers) and Nanoparticle-Based Drug Delivery (4 papers). Meshkat Dinarvand is often cited by papers focused on RNA Interference and Gene Delivery (12 papers), Advanced biosensing and bioanalysis techniques (8 papers) and Nanoparticle-Based Drug Delivery (4 papers). Meshkat Dinarvand collaborates with scholars based in Iran, Germany and United States. Meshkat Dinarvand's co-authors include Fatemeh Atyabi, Rassoul Dinarvand, Sebastian Kruss, Mohsen Amini, Morteza Azhdarzadeh, Gabriele Selvaggio, Luise Erpenbeck, Florian A. Mann, Elsa Neubert and Daniel Meyer and has published in prestigious journals such as Nano Letters, Carbohydrate Polymers and International Journal of Pharmaceutics.

In The Last Decade

Meshkat Dinarvand

18 papers receiving 866 citations

Peers

Countries citing papers authored by Meshkat Dinarvand

Since Specialization

Citations

This map shows the geographic impact of Meshkat Dinarvand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meshkat Dinarvand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meshkat Dinarvand more than expected).

Fields of papers citing papers by Meshkat Dinarvand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meshkat Dinarvand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meshkat Dinarvand. The network helps show where Meshkat Dinarvand may publish in the future.

Co-authorship network of co-authors of Meshkat Dinarvand

This figure shows the co-authorship network connecting the top 25 collaborators of Meshkat Dinarvand. A scholar is included among the top collaborators of Meshkat Dinarvand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meshkat Dinarvand. Meshkat Dinarvand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Reactive oxygen species (ROS) are a crucial factor in the anticancer activity of Oliveria decumbens extract against the A431 human skin cell line 2024 ·Archives of Razi Institute ·Meshkat Dinarvand, (unknown), Zohreh Jangravi	1
2	Trimethyl-Chitosan Coated Gold Nanoparticles Enhance Delivery, Cellular Uptake and Gene Silencing Effect of EGFR-siRNA in Breast Cancer Cells 2022 ·Frontiers in Molecular Biosciences ·(unknown), (unknown), (unknown), (unknown), Meshkat Dinarvand, Fatemeh Atyabi	30
3	Covalently Functionalized Egyptian Blue Nanosheets for Near-Infrared Bioimaging 2022 ·ACS Applied Bio Materials ·Gabriele Selvaggio, Niklas Herrmann, (unknown), Rıza Dervişoğlu, (unknown), (unknown), Meshkat Dinarvand, Dietmar Stalke, Loren B. Andreas, Sebastian Kruss	4
4	Imaging of Monoamine Neurotransmitters with Fluorescent Nanoscale Sensors 2020 ·ChemPlusChem ·Meshkat Dinarvand, (unknown), James Daniel, Sebastian Kruss	30
5	Immobilization of HIV‐1 TAT peptide on gold nanoparticles: A feasible approach for siRNA delivery 2019 ·Journal of Cellular Physiology ·(unknown), Melika Kiani, Meshkat Dinarvand, (unknown), Farnaz Sadat Mirzazadeh Tekie, Rasoul Dinarvand, Fatemeh Atyabi	18
6	Near-Infrared Imaging of Serotonin Release from Cells with Fluorescent Nanosensors 2019 ·Nano Letters ·Meshkat Dinarvand, Elsa Neubert, Daniel Meyer, Gabriele Selvaggio, Florian A. Mann, Luise Erpenbeck, Sebastian Kruss	106
7	Glutathione responsive chitosan-thiolated dextran conjugated miR-145 nanoparticles targeted with AS1411 aptamer for cancer treatment 2018 ·Carbohydrate Polymers ·Farnaz Sadat Mirzazadeh Tekie, Masoud Soleimani, (unknown), Meshkat Dinarvand, Mohsen Amini, Rassoul Dinarvand, Ehsan Arefian, Fatemeh Atyabi	47
8	Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA 2018 ·Nature Biomedical Engineering ·Mohammad Ariful Islam, Yingjie Xu, Wei Tao, Jessalyn M. Ubellacker, (unknown), (unknown), Gha Young Lee, Kun Zhou, Harshal Zope, Mikyung Yu, Wuji Cao, James Trevor Oswald, Meshkat Dinarvand, Morteza Mahmoudi, Róbert Langer, Philip W. Kantoff, Omid C. Farokhzad, Bruce R. Zetter, Jinjun Shi	263
9	Multifunctional core-shell nanoplatforms (gold@graphene oxide) with mediated NIR thermal therapy to promote miRNA delivery 2018 ·Nanomedicine Nanotechnology Biology and Medicine ·(unknown), Omid Akhavan, Mohsen Adeli, (unknown), Rassoul Dinarvand, Saeid Zanganeh, Masoud Soleimani, Meshkat Dinarvand, Fatemeh Atyabi	59
10	siRNA delivery for treatment of degenerative diseases, new hopes and challenges 2018 ·Journal of Drug Delivery Science and Technology ·Forouhe Zahir‐Jouzdani, Fatemeh Mottaghitalab, Meshkat Dinarvand, Fatemeh Atyabi	26
11	Application of nanostructured lipid carriers: the prolonged protective effects for sesamol in in vitro and in vivo models of ischemic stroke via activation of PI3K signalling pathway 2017 ·DARU Journal of Pharmaceutical Sciences ·Parichehr Hassanzadeh, Fatemeh Atyabi, Rassoul Dinarvand, Ahmad Reza Dehpour, Morteza Azhdarzadeh, Meshkat Dinarvand	35
12	Prospects of siRNA applications in regenerative medicine 2017 ·International Journal of Pharmaceutics ·Fatemeh Mottaghitalab, Ali Rastegari, Mehdi Farokhi, Rassoul Dinarvand, Hossein Hosseinkhani, Keng‐Liang Ou, Daniel W. Pack, Chuanbin Mao, Meshkat Dinarvand, Yousef Fatahi, Fatemeh Atyabi	26
13	Inhibiting influenza virus replication and inducing protection against lethal influenza virus challenge through chitosan nanoparticles loaded by siRNA 2017 ·Drug Delivery and Translational Research ·Abbas Jamali, Fatemeh Mottaghitalab, Asghar Abdoli, Meshkat Dinarvand, (unknown), Masoumeh Tavassoti Kheiri, Fatemeh Atyabi	36
14	Thiolated carboxymethyl dextran as a nanocarrier for colon delivery of hSET1 antisense: In vitro stability and efficiency study 2016 ·Materials Science and Engineering C ·Melika Kiani, Farnaz Sadat Mirzazadeh Tekie, Meshkat Dinarvand, Masoud Soleimani, Rassoul Dinarvand, Fatemeh Atyabi	28
15	Docetaxel–Chitosan nanoparticles for breast cancer treatment: cell viability and gene expression study 2016 ·Chemical Biology & Drug Design ·Zahra Mirzaie, Shiva Irani, Reza Mirfakhraie, Seyed Mohammad Atyabi, Meshkat Dinarvand, Rassoul Dinarvand, Reyhaneh Varshochian, Fatemeh Atyabi	40
16	Oral delivery of nanoparticles containing anticancer SN38 and hSET1 antisense for dual therapy of colon cancer 2015 ·International Journal of Biological Macromolecules ·Meshkat Dinarvand, Melika Kiani, (unknown), (unknown), Zahra Mirzaie, Masoud Soleimani, Rassoul Dinarvand, Fatemeh Atyabi	28
17	MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery 2014 ·International Journal of Pharmaceutics ·(unknown), Meshkat Dinarvand, Mohsen Amini, Morteza Azhdarzadeh, (unknown), Zahra Ghasemi, Fatemeh Atyabi	76
18	Chitosan nanoparticles as a potential nonviral gene delivery for HPV-16 E7 into mammalian cells 2014 ·Artificial Cells Nanomedicine and Biotechnology ·Alireza Tahamtan, Alijan Tabarraei, Abdolvahab Moradi, Meshkat Dinarvand, (unknown), Amir Ghaemi, Fatemeh Atyabi	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact